Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei Sarlea

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACR Open Rheumatology|June 23, 2026
Colchicine Inhibits Chemokine Production in Monosodium Urate-Stimulated Innate Immune CellsLaura M Merlo Pich, Titus Schlüter, Andrei Sarlea, et al.
Journal of Leukocyte Biology|June 4, 2025
Arginine metabolism supports metabolic reprogramming in trained immunityLaura M Merlo Pich, Athanasios Ziogas, Anaisa V Ferreira, et al.
Tuberculosis (Edinburgh, Scotland)|May 21, 2026
Early clearance of Mycobacterium tuberculosis among Indonesian household contacts is not associated with circulating beta-glucan present at the time of exposureTodia P Setiabudiawan, Lika Apriani, Marlou Tehupeiory-Kooreman, et al.
Frontiers in Immunology|February 28, 2024
Potent induction of trained immunity by <i>Saccharomyces cerevisiae</i> β-glucansPatricia Vuscan, Brenda Kischkel, Aikaterini Hatzioannou, et al.
British Journal of Clinical Pharmacology|September 28, 2020
Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuriaGaby A M Eliesen, Joris van Drongelen, Petra H H van den Broek, et al.
Communications Medicine|January 21, 2025
Preclinical assessment of splicing modulation therapy for ABCA4 variant c.768G>T in Stargardt diseaseDyah W Karjosukarso, Femke Bukkems, Lonneke Duijkers, et al.
Cellular & Molecular Immunology|March 27, 2020
The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatmentLambertus P van den Heuvel, Nicole C A J van de Kar, Caroline Duineveld, et al.
Molecular Systems Biology|September 10, 2025
Deciphering cross-cohort metabolic signatures of immune responses and their implications for disease pathogenesisJianbo Fu, Nienke van Unen, Andrei Sarlea, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
Cell Genomics|April 18, 2026
Interferon-related inflammaging links epigenetic age acceleration to multimorbidityZhaoli Liu, Athanasios Ziogas, Yihan Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACR Open Rheumatology|June 23, 2026
Colchicine Inhibits Chemokine Production in Monosodium Urate-Stimulated Innate Immune CellsLaura M Merlo Pich, Titus Schlüter, Andrei Sarlea, et al.
Journal of Leukocyte Biology|June 4, 2025
Arginine metabolism supports metabolic reprogramming in trained immunityLaura M Merlo Pich, Athanasios Ziogas, Anaisa V Ferreira, et al.
Tuberculosis (Edinburgh, Scotland)|May 21, 2026
Early clearance of Mycobacterium tuberculosis among Indonesian household contacts is not associated with circulating beta-glucan present at the time of exposureTodia P Setiabudiawan, Lika Apriani, Marlou Tehupeiory-Kooreman, et al.
Frontiers in Immunology|February 28, 2024
Potent induction of trained immunity by <i>Saccharomyces cerevisiae</i> β-glucansPatricia Vuscan, Brenda Kischkel, Aikaterini Hatzioannou, et al.
British Journal of Clinical Pharmacology|September 28, 2020
Placental disposition of eculizumab, C5 and C5-eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuriaGaby A M Eliesen, Joris van Drongelen, Petra H H van den Broek, et al.
Communications Medicine|January 21, 2025
Preclinical assessment of splicing modulation therapy for ABCA4 variant c.768G>T in Stargardt diseaseDyah W Karjosukarso, Femke Bukkems, Lonneke Duijkers, et al.
Cellular & Molecular Immunology|March 27, 2020
The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatmentLambertus P van den Heuvel, Nicole C A J van de Kar, Caroline Duineveld, et al.
Molecular Systems Biology|September 10, 2025
Deciphering cross-cohort metabolic signatures of immune responses and their implications for disease pathogenesisJianbo Fu, Nienke van Unen, Andrei Sarlea, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
Cell Genomics|April 18, 2026
Interferon-related inflammaging links epigenetic age acceleration to multimorbidityZhaoli Liu, Athanasios Ziogas, Yihan Zhang, et al.
Pageof 1